Edwards Lifesciences Cash Flow from Financial Activities 2010-2025 | EW
Edwards Lifesciences annual/quarterly cash flow from financial activities history and growth rate from 2010 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
- Edwards Lifesciences cash flow from financial activities for the quarter ending March 31, 2025 was $-0.258B, a 518.15% decline year-over-year.
- Edwards Lifesciences cash flow from financial activities for the twelve months ending March 31, 2025 was $-2.288B, a 107.65% increase year-over-year.
- Edwards Lifesciences annual cash flow from financial activities for 2024 was $-0.983B, a 38.26% increase from 2023.
- Edwards Lifesciences annual cash flow from financial activities for 2023 was $-0.711B, a 55.13% decline from 2022.
- Edwards Lifesciences annual cash flow from financial activities for 2022 was $-1.585B, a 344.71% increase from 2021.
| Edwards Lifesciences Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2024 | $-983 |
| 2023 | $-711 |
| 2022 | $-1,585 |
| 2021 | $-356 |
| 2020 | $-487 |
| 2019 | $-116 |
| 2018 | $-1,101 |
| 2017 | $-473 |
| 2016 | $-269 |
| 2015 | $-159 |
| 2014 | $-153 |
| 2013 | $35 |
| 2012 | $-156 |
| 2011 | $-135 |
| 2010 | $-104 |
| 2009 | $-92 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $45.667B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.979B | 87.59 |
| Thermo Fisher Scientific (TMO) | United States | $152.379B | 18.43 |
| Alcon (ALC) | Switzerland | $42.389B | 28.65 |
| IDEXX Laboratories (IDXX) | United States | $42.210B | 48.51 |
| DexCom (DXCM) | United States | $33.568B | 51.88 |
| IQVIA Holdings (IQV) | United States | $25.587B | 14.33 |
| Mettler-Toledo (MTD) | United States | $24.309B | 28.91 |
| STERIS (STE) | Ireland | $23.816B | 26.23 |
| Waters (WAT) | United States | $21.016B | 29.65 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.484B | 0.00 |
| Hologic (HOLX) | United States | $13.943B | 15.15 |
| Sysmex ADR (SSMXY) | Japan | $10.323B | 29.29 |
| Penumbra (PEN) | United States | $9.888B | 77.61 |
| Masimo (MASI) | United States | $8.836B | 32.59 |
| Globus Medical (GMED) | United States | $8.077B | 19.25 |
| Teleflex (TFX) | United States | $5.424B | 8.95 |
| Glaukos (GKOS) | United States | $5.198B | 0.00 |
| TransMedics (TMDX) | United States | $4.391B | 95.45 |
| Integer Holdings (ITGR) | United States | $4.193B | 21.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.410B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.425B | 14.44 |
| Nihon Kohden (NHNKY) | Japan | $2.244B | 25.74 |
| Veracyte (VCYT) | United States | $2.137B | 29.99 |
| Elekta AB (EKTAY) | Sweden | $1.968B | 17.69 |
| Alphatec Holdings (ATEC) | United States | $1.795B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.344B | 0.00 |
| Artivion (AORT) | United States | $1.224B | 114.64 |
| Pulse Biosciences (PLSE) | United States | $1.181B | 0.00 |
| OPKO Health (OPK) | United States | $1.067B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.018B | 5.41 |
| Beta Bionics (BBNX) | United States | $0.843B | 0.00 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| IRadimed (IRMD) | United States | $0.773B | 39.21 |
| RxSight (RXST) | United States | $0.620B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.577B | 8.97 |
| Delcath Systems (DCTH) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.551B | 12.91 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.489B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.445B | 0.00 |
| NeuroPace (NPCE) | United States | $0.432B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.427B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.399B | 10.61 |
| ClearPoint Neuro (CLPT) | United States | $0.364B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.363B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.309B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.247B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.28 |
| Sight Sciences (SGHT) | United States | $0.219B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.207B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.159B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 48.90 |
| InspireMD (NSPR) | United States | $0.080B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.12 |